Pharma

Fresenius SE

Symbol: FRE.DE
39.61 €
+0.76%
KGV
14.8
Dividende
2.65%
Marktkap.
22.3 Mrd
52W Hoch
52.96 €
52W Tief
35.11 €

Live Chart

Über Fresenius SE

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment offers products for therapy and care of critically and chronically ill patients, including biopharmaceuticals, clinical nutrition, MedTech products, intravenously administered generic drugs, and IV fluids. It also provides biosimilar drugs; enteral and parenteral nutrition products; and medical technologies that include disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment operates hospitals, medical care centers, occupational health centers, prevention centers, and outpatient health centers, as well as provision of medical diagnostics. The company has a strategic collaboration with SAP SE and Avelios Medical GmbH for the development of a cloud-native,

Aktuelle Finanznachrichten

Hinweis: Diese Daten dienen nur zur Information und stellen keine Anlageberatung dar. Aktualisiert: 21.06.2026 11:00
| YouTube